Vertex Pharmaceuticals (VRTX) Shares Outstanding (Diluted Average) (2009 - 2026)

Vertex Pharmaceuticals' Shares Outstanding (Diluted Average) history runs 18 years deep, the most recent figure standing at $256.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 1.23% year-over-year to $256.3 million; the TTM figure through Mar 2026 stood at $256.3 million (down 1.23% YoY), while the FY2025 annual figure was $258.0 million, changed 0.04% from the prior year.
• Shares Outstanding (Diluted Average) was $256.3 million for Q1 2026 at Vertex Pharmaceuticals, down from $258.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $261.1 million in Q1 2024 to a low of $256.3 million in Q1 2026.
• Historically, Shares Outstanding (Diluted Average) has averaged $259.0 million across 5 years, with a median of $258.9 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) decreased 1.53% in 2022, then increased 0.93% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $259.1 million in 2022, then increased by 0.54% to $260.5 million in 2023, then slipped by 1.0% to $257.9 million in 2024, then gained by 0.04% to $258.0 million in 2025, then dropped by 0.66% to $256.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $256.3 million (Q1 2026), $258.0 million (Q4 2025), and $257.6 million (Q3 2025), per Business Quant data.